Literature DB >> 32111640

Incidence, risk factors and outcome of young patients with myocardial infarction.

Jarle Jortveit1, Are Hugo Pripp2, Jørund Langørgen3, Sigrun Halvorsen4.   

Abstract

OBJECTIVE: The decline in the incidence and mortality of acute myocardial infarction (AMI) has been less among younger compared with older individuals. The aim of this nationwide study was to assess the current incidence, risk factors and outcome of AMI in patients <45 years of age.
METHODS: All patients ≤80 years of age registered in the Norwegian Myocardial Infarction Register in 2013-2016 were included in this observational, nationwide cohort study. Follow-up was conducted through linkage with the Norwegian Patient Registry through 2017.
RESULTS: Among a total of 33 439 patients ≤80 years with AMI, 1468 (4.4%) were <45 years old. The incidence of AMI was 2.1 per 100 000 person-years in people aged 20-29 years, 16.9 in people aged 30-39 years and 97.6 in people aged 40-49 years. Compared with older patients, patients <45 years were more likely to be male (81%), current smokers (56%), obese (30%) and have a family history of premature AMI (44%), and their low-density lipoprotein-cholesterol levels were higher. Patients <45 years were more likely to have non-obstructive coronary artery disease (14% vs 10%, p<0.001) compared with older patients. During a median follow-up time of 2.4 years, 135 (9%) patients <45 years experienced a new AMI, stroke or death, and 58 (4%) patients died.
CONCLUSIONS: The rate of AMI was low in people <45 years old in Norway, but almost one in ten patients with AMI <45 years old died or experienced a new cardiovascular event during follow-up. Increased efforts to improve risk factor control in these patients are warranted. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  acute myocardial infarction

Mesh:

Year:  2020        PMID: 32111640     DOI: 10.1136/heartjnl-2019-316067

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  10 in total

1.  Associations between hyperhomocysteinemia and the presence and severity of acute coronary syndrome in young adults ≤ 35 years of age.

Authors:  Jiayin Sun; Wei Han; Sijing Wu; Shuo Jia; Zhenxian Yan; Yonghe Guo; Yingxin Zhao; Yujie Zhou; Wei Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-01-23       Impact factor: 2.298

2.  Acute Myocardial Infarction in Young Men Under 50 Years of Age: Clinical Characteristics, Treatment, and Long-Term Prognosis.

Authors:  Hui Gao; Yuan Wang; Aidong Shen; Hui Chen; Hongwei Li
Journal:  Int J Gen Med       Date:  2021-12-04

3.  Changes in the Quality of Life, Psychological Status, Medication Compliance, and Prognosis of Patients with Acute Myocardial Infarction after PCI by Applying PDCA Cycle Management Model.

Authors:  Yan Li; Mei Hong; Guohui Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-19       Impact factor: 2.629

4.  Plasma Quantitative Lipid Profiles: Identification of CarnitineC18:1-OH, CarnitineC18:2-OH and FFA (20:1) as Novel Biomarkers for Pre-warning and Prognosis in Acute Myocardial Infarction.

Authors:  Jun Liu; Liangqiu Tang; Qiqi Lu; Yi Yu; Qiu-Gui Xu; Shanqiang Zhang; Yun-Xian Chen; Wen-Jie Dai; Ji-Cheng Li
Journal:  Front Cardiovasc Med       Date:  2022-04-11

5.  MiR-223-3p affects myocardial inflammation and apoptosis following myocardial infarction via targeting FBXW7.

Authors:  Libin Zhang; Jing Yang; Ming Guo; Minghui Hao
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

6.  Time trends in incidence, treatment, and outcome in acute myocardial infarction in Norway 2013-19.

Authors:  Jarle Jortveit; Are Hugo Pripp; Jørund Langørgen; Sigrun Halvorsen
Journal:  Eur Heart J Open       Date:  2022-08-10

7.  ST-Elevation Acute Myocardial Infarction in a Young Man.

Authors:  Daisuke Usuda; Risa Tanaka; Makoto Suzuki; Hayabusa Takano; Yuta Hotchi; Shintaro Shimozawa; Shungo Tokunaga; Ippei Osugi; Risa Katou; Sakurako Ito; Kentaro Mishima; Akihiko Kondo; Keiko Mizuno; Hiroki Takami; Takayuki Komatsu; Jiro Oba; Tomohisa Nomura; Manabu Sugita
Journal:  J Med Cases       Date:  2022-06-02

8.  The effects of Anisodamine-Tirofiban Combined Therapy in acute myocardial infarction treated with Percutaneous Coronary Intervention (PCI).

Authors:  Yan Jiao; Xiaoying Fu; Qingxin Liu; Wei Zhang
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

9.  Gender differences in clinical characteristics and in-hospital and one-year outcomes of young patients with ST-segment elevation myocardial infarction under the age of 40.

Authors:  Bektas Murat; Eylem Kivanc; Rafet Dizman; Gurbet Ozge Mert; Selda Murat
Journal:  J Cardiovasc Thorac Res       Date:  2021-02-08

Review 10.  [Infarto agudo de miocardio: revisión sobre factores de riesgo, etiología, hallazgos angiográficos y desenlaces en pacientes jóvenes].

Authors:  Carlos A Dattoli-García; Cynthia N Jackson-Pedroza; Andrea L Gallardo-Grajeda; Rodrigo Gopar-Nieto; Diego Araiza-Garygordobil; Alexandra Arias-Mendoza
Journal:  Arch Cardiol Mex       Date:  2021-11-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.